BamSEC and AlphaSense Join Forces
Learn More

Adial Pharmaceuticals Inc – Material Contracts

NASDAQ: ADIL    
Share price (3/13/26): $1.96    
Market cap (3/13/26): $2.799 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 13 pages Form of Warrant Inducement Agreement, Dated November 25, 2025, by and Between Adial Pharmaceuticals, Inc. and Holder
12/34/56
EX-10.1
from 8-K 1 page Amendment No. 7 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan
12/34/56
EX-10.2
from 8-K 3 pages Amendment No. 1 to Series B-1 Common Stock Purchase Warrant and Series C-1 Common Stock Purchase Warrant
12/34/56
EX-10.1
from 8-K 32 pages Securities Purchase Agreement
12/34/56
EX-10.48
from S-1 33 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 15 pages Form of Warrant Inducement Agreement by and Between Adial Pharmaceuticals, Inc. and Holder
12/34/56
EX-10.1
from 8-K 27 pages Employment Agreement
12/34/56
EX-10.2
from 8-K 2 pages Termination Agreement
12/34/56
EX-10.1
from 8-K 26 pages Purchase Agreement
12/34/56
EX-10.1
from 8-K 27 pages Amended and Restated Employment Agreement
12/34/56
EX-10.1
from 8-K 1 page Amendment No. 6 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan
12/34/56
EX-10.2
from 8-K 24 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 12 pages Via Fedex and U.S. Mail November 1, 2024 Personal and Confidential This Letter Follows Up Our Discussion Concerning Your Resignation of Your Position With Adial Pharmaceuticals, Inc. (The “Company”). in Recognition of Your Long Service and Dedication to the Company, the Company Is Proposing a Separation Agreement (The “Agreement”) as Follows: 1. Separation From Employment. on the Expressed Condition That You Sign and Return This Agreement by 6:00 Pm (Edt) on November 1, 2024 and Do Not Subsequently Revoke Such Execution and Agreement, the Company Agrees to the Following Services and Compensation
12/34/56
EX-10.1
from 8-K 8 pages Separation Agreement and Release
12/34/56
EX-10.1
from 8-K 9 pages Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.2
from 8-K 2 pages Attachment “A” Statement of Work #2
12/34/56
EX-10.1
from 8-K 1 page Amendment No. 5 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan
12/34/56
EX-10.2
from 8-K 26 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 40 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 25 pages Purchase Agreement
12/34/56